0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Oncology Drug Discovery Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-25E5775
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oncology Drug Discovery Services Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Oncology Drug Discovery Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-25E5775
Report
November 2024
Pages:130
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oncology Drug Discovery Services - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Oncology Drug Discovery Services - Market

Oncology Drug Discovery Services - Market

The Oncology Drug Discovery Service is dedicated to oncology research, providing high-quality, timely and cost-effective oncology drug discovery and accelerating the development of the immunooncology product portfolio to develop new drugs that benefit human health.
The global market for Oncology Drug Discovery Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncology Drug Discovery Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Oncology Drug Discovery Services by region & country, by Type, and by Application.
The Oncology Drug Discovery Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Drug Discovery Services.
Market Segmentation

Scope of Oncology Drug Discovery Services - Market Report

Report Metric Details
Report Name Oncology Drug Discovery Services - Market
CAGR 5%
Segment by Type:
  • Identification Service
  • Authentication Service
  • Hit-to-lead and Lead Optimization Services
  • Others
Segment by Application
  • Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River, Evotec, GE Healthcare Life Sciences, GenScript, Horizon Discovery, TCG Lifesciences, Zumutor, ChemPartner, Aquila BioMedical, Onconova, Vichem Chemie, GVK Biosciences, NuChem Therapeutics, Syncom, Envigo, DiverChim, Aurora, HD Biosciences, WuXi AppTec
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Oncology Drug Discovery Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Oncology Drug Discovery Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Oncology Drug Discovery Services in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Oncology Drug Discovery Services - Market report?

Ans: The main players in the Oncology Drug Discovery Services - Market are Charles River, Evotec, GE Healthcare Life Sciences, GenScript, Horizon Discovery, TCG Lifesciences, Zumutor, ChemPartner, Aquila BioMedical, Onconova, Vichem Chemie, GVK Biosciences, NuChem Therapeutics, Syncom, Envigo, DiverChim, Aurora, HD Biosciences, WuXi AppTec

What are the Application segmentation covered in the Oncology Drug Discovery Services - Market report?

Ans: The Applications covered in the Oncology Drug Discovery Services - Market report are Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Others

What are the Type segmentation covered in the Oncology Drug Discovery Services - Market report?

Ans: The Types covered in the Oncology Drug Discovery Services - Market report are Identification Service, Authentication Service, Hit-to-lead and Lead Optimization Services, Others

1 Market Overview
1.1 Oncology Drug Discovery Services Product Introduction
1.2 Global Oncology Drug Discovery Services Market Size Forecast
1.3 Oncology Drug Discovery Services Market Trends & Drivers
1.3.1 Oncology Drug Discovery Services Industry Trends
1.3.2 Oncology Drug Discovery Services Market Drivers & Opportunity
1.3.3 Oncology Drug Discovery Services Market Challenges
1.3.4 Oncology Drug Discovery Services Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oncology Drug Discovery Services Players Revenue Ranking (2023)
2.2 Global Oncology Drug Discovery Services Revenue by Company (2019-2024)
2.3 Key Companies Oncology Drug Discovery Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Oncology Drug Discovery Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Oncology Drug Discovery Services
2.6 Oncology Drug Discovery Services Market Competitive Analysis
2.6.1 Oncology Drug Discovery Services Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Oncology Drug Discovery Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drug Discovery Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Identification Service
3.1.2 Authentication Service
3.1.3 Hit-to-lead and Lead Optimization Services
3.1.4 Others
3.2 Global Oncology Drug Discovery Services Sales Value by Type
3.2.1 Global Oncology Drug Discovery Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Oncology Drug Discovery Services Sales Value, by Type (2019-2030)
3.2.3 Global Oncology Drug Discovery Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research Institutes
4.1.2 Pharmaceutical Companies
4.1.3 Biotechnology Companies
4.1.4 Others
4.2 Global Oncology Drug Discovery Services Sales Value by Application
4.2.1 Global Oncology Drug Discovery Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Oncology Drug Discovery Services Sales Value, by Application (2019-2030)
4.2.3 Global Oncology Drug Discovery Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Oncology Drug Discovery Services Sales Value by Region
5.1.1 Global Oncology Drug Discovery Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Oncology Drug Discovery Services Sales Value by Region (2019-2024)
5.1.3 Global Oncology Drug Discovery Services Sales Value by Region (2025-2030)
5.1.4 Global Oncology Drug Discovery Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Oncology Drug Discovery Services Sales Value, 2019-2030
5.2.2 North America Oncology Drug Discovery Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Oncology Drug Discovery Services Sales Value, 2019-2030
5.3.2 Europe Oncology Drug Discovery Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Oncology Drug Discovery Services Sales Value, 2019-2030
5.4.2 Asia Pacific Oncology Drug Discovery Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Oncology Drug Discovery Services Sales Value, 2019-2030
5.5.2 South America Oncology Drug Discovery Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Oncology Drug Discovery Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Oncology Drug Discovery Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oncology Drug Discovery Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Oncology Drug Discovery Services Sales Value
6.3 United States
6.3.1 United States Oncology Drug Discovery Services Sales Value, 2019-2030
6.3.2 United States Oncology Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Oncology Drug Discovery Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Oncology Drug Discovery Services Sales Value, 2019-2030
6.4.2 Europe Oncology Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Oncology Drug Discovery Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Oncology Drug Discovery Services Sales Value, 2019-2030
6.5.2 China Oncology Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Oncology Drug Discovery Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Oncology Drug Discovery Services Sales Value, 2019-2030
6.6.2 Japan Oncology Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Oncology Drug Discovery Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Oncology Drug Discovery Services Sales Value, 2019-2030
6.7.2 South Korea Oncology Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Oncology Drug Discovery Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Oncology Drug Discovery Services Sales Value, 2019-2030
6.8.2 Southeast Asia Oncology Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Oncology Drug Discovery Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Oncology Drug Discovery Services Sales Value, 2019-2030
6.9.2 India Oncology Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Oncology Drug Discovery Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Charles River
7.1.1 Charles River Profile
7.1.2 Charles River Main Business
7.1.3 Charles River Oncology Drug Discovery Services Products, Services and Solutions
7.1.4 Charles River Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.1.5 Charles River Recent Developments
7.2 Evotec
7.2.1 Evotec Profile
7.2.2 Evotec Main Business
7.2.3 Evotec Oncology Drug Discovery Services Products, Services and Solutions
7.2.4 Evotec Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.2.5 Evotec Recent Developments
7.3 GE Healthcare Life Sciences
7.3.1 GE Healthcare Life Sciences Profile
7.3.2 GE Healthcare Life Sciences Main Business
7.3.3 GE Healthcare Life Sciences Oncology Drug Discovery Services Products, Services and Solutions
7.3.4 GE Healthcare Life Sciences Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.3.5 GenScript Recent Developments
7.4 GenScript
7.4.1 GenScript Profile
7.4.2 GenScript Main Business
7.4.3 GenScript Oncology Drug Discovery Services Products, Services and Solutions
7.4.4 GenScript Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.4.5 GenScript Recent Developments
7.5 Horizon Discovery
7.5.1 Horizon Discovery Profile
7.5.2 Horizon Discovery Main Business
7.5.3 Horizon Discovery Oncology Drug Discovery Services Products, Services and Solutions
7.5.4 Horizon Discovery Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.5.5 Horizon Discovery Recent Developments
7.6 TCG Lifesciences
7.6.1 TCG Lifesciences Profile
7.6.2 TCG Lifesciences Main Business
7.6.3 TCG Lifesciences Oncology Drug Discovery Services Products, Services and Solutions
7.6.4 TCG Lifesciences Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.6.5 TCG Lifesciences Recent Developments
7.7 Zumutor
7.7.1 Zumutor Profile
7.7.2 Zumutor Main Business
7.7.3 Zumutor Oncology Drug Discovery Services Products, Services and Solutions
7.7.4 Zumutor Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.7.5 Zumutor Recent Developments
7.8 ChemPartner
7.8.1 ChemPartner Profile
7.8.2 ChemPartner Main Business
7.8.3 ChemPartner Oncology Drug Discovery Services Products, Services and Solutions
7.8.4 ChemPartner Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.8.5 ChemPartner Recent Developments
7.9 Aquila BioMedical
7.9.1 Aquila BioMedical Profile
7.9.2 Aquila BioMedical Main Business
7.9.3 Aquila BioMedical Oncology Drug Discovery Services Products, Services and Solutions
7.9.4 Aquila BioMedical Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.9.5 Aquila BioMedical Recent Developments
7.10 Onconova
7.10.1 Onconova Profile
7.10.2 Onconova Main Business
7.10.3 Onconova Oncology Drug Discovery Services Products, Services and Solutions
7.10.4 Onconova Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.10.5 Onconova Recent Developments
7.11 Vichem Chemie
7.11.1 Vichem Chemie Profile
7.11.2 Vichem Chemie Main Business
7.11.3 Vichem Chemie Oncology Drug Discovery Services Products, Services and Solutions
7.11.4 Vichem Chemie Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.11.5 Vichem Chemie Recent Developments
7.12 GVK Biosciences
7.12.1 GVK Biosciences Profile
7.12.2 GVK Biosciences Main Business
7.12.3 GVK Biosciences Oncology Drug Discovery Services Products, Services and Solutions
7.12.4 GVK Biosciences Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.12.5 GVK Biosciences Recent Developments
7.13 NuChem Therapeutics
7.13.1 NuChem Therapeutics Profile
7.13.2 NuChem Therapeutics Main Business
7.13.3 NuChem Therapeutics Oncology Drug Discovery Services Products, Services and Solutions
7.13.4 NuChem Therapeutics Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.13.5 NuChem Therapeutics Recent Developments
7.14 Syncom
7.14.1 Syncom Profile
7.14.2 Syncom Main Business
7.14.3 Syncom Oncology Drug Discovery Services Products, Services and Solutions
7.14.4 Syncom Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.14.5 Syncom Recent Developments
7.15 Envigo
7.15.1 Envigo Profile
7.15.2 Envigo Main Business
7.15.3 Envigo Oncology Drug Discovery Services Products, Services and Solutions
7.15.4 Envigo Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.15.5 Envigo Recent Developments
7.16 DiverChim
7.16.1 DiverChim Profile
7.16.2 DiverChim Main Business
7.16.3 DiverChim Oncology Drug Discovery Services Products, Services and Solutions
7.16.4 DiverChim Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.16.5 DiverChim Recent Developments
7.17 Aurora
7.17.1 Aurora Profile
7.17.2 Aurora Main Business
7.17.3 Aurora Oncology Drug Discovery Services Products, Services and Solutions
7.17.4 Aurora Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.17.5 Aurora Recent Developments
7.18 HD Biosciences
7.18.1 HD Biosciences Profile
7.18.2 HD Biosciences Main Business
7.18.3 HD Biosciences Oncology Drug Discovery Services Products, Services and Solutions
7.18.4 HD Biosciences Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.18.5 HD Biosciences Recent Developments
7.19 WuXi AppTec
7.19.1 WuXi AppTec Profile
7.19.2 WuXi AppTec Main Business
7.19.3 WuXi AppTec Oncology Drug Discovery Services Products, Services and Solutions
7.19.4 WuXi AppTec Oncology Drug Discovery Services Revenue (US$ Million) & (2019-2024)
7.19.5 WuXi AppTec Recent Developments
8 Industry Chain Analysis
8.1 Oncology Drug Discovery Services Industrial Chain
8.2 Oncology Drug Discovery Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oncology Drug Discovery Services Sales Model
8.5.2 Sales Channel
8.5.3 Oncology Drug Discovery Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Oncology Drug Discovery Services Market Trends
    Table 2. Oncology Drug Discovery Services Market Drivers & Opportunity
    Table 3. Oncology Drug Discovery Services Market Challenges
    Table 4. Oncology Drug Discovery Services Market Restraints
    Table 5. Global Oncology Drug Discovery Services Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Oncology Drug Discovery Services Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Oncology Drug Discovery Services Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Oncology Drug Discovery Services Product Type
    Table 9. Key Companies Time to Begin Mass Production of Oncology Drug Discovery Services
    Table 10. Global Oncology Drug Discovery Services Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drug Discovery Services as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Oncology Drug Discovery Services Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Oncology Drug Discovery Services Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Oncology Drug Discovery Services Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Oncology Drug Discovery Services Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Oncology Drug Discovery Services Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Oncology Drug Discovery Services Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Oncology Drug Discovery Services Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Oncology Drug Discovery Services Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Oncology Drug Discovery Services Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Oncology Drug Discovery Services Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Oncology Drug Discovery Services Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Oncology Drug Discovery Services Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Oncology Drug Discovery Services Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Oncology Drug Discovery Services Sales Value by Region (2019-2024) & (%)
    Table 27. Global Oncology Drug Discovery Services Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Oncology Drug Discovery Services Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Oncology Drug Discovery Services Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Oncology Drug Discovery Services Sales Value, (2025-2030) & (US$ Million)
    Table 31. Charles River Basic Information List
    Table 32. Charles River Description and Business Overview
    Table 33. Charles River Oncology Drug Discovery Services Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Oncology Drug Discovery Services Business of Charles River (2019-2024)
    Table 35. Charles River Recent Developments
    Table 36. Evotec Basic Information List
    Table 37. Evotec Description and Business Overview
    Table 38. Evotec Oncology Drug Discovery Services Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Oncology Drug Discovery Services Business of Evotec (2019-2024)
    Table 40. Evotec Recent Developments
    Table 41. GE Healthcare Life Sciences Basic Information List
    Table 42. GE Healthcare Life Sciences Description and Business Overview
    Table 43. GE Healthcare Life Sciences Oncology Drug Discovery Services Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Oncology Drug Discovery Services Business of GE Healthcare Life Sciences (2019-2024)
    Table 45. GE Healthcare Life Sciences Recent Developments
    Table 46. GenScript Basic Information List
    Table 47. GenScript Description and Business Overview
    Table 48. GenScript Oncology Drug Discovery Services Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Oncology Drug Discovery Services Business of GenScript (2019-2024)
    Table 50. GenScript Recent Developments
    Table 51. Horizon Discovery Basic Information List
    Table 52. Horizon Discovery Description and Business Overview
    Table 53. Horizon Discovery Oncology Drug Discovery Services Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Oncology Drug Discovery Services Business of Horizon Discovery (2019-2024)
    Table 55. Horizon Discovery Recent Developments
    Table 56. TCG Lifesciences Basic Information List
    Table 57. TCG Lifesciences Description and Business Overview
    Table 58. TCG Lifesciences Oncology Drug Discovery Services Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Oncology Drug Discovery Services Business of TCG Lifesciences (2019-2024)
    Table 60. TCG Lifesciences Recent Developments
    Table 61. Zumutor Basic Information List
    Table 62. Zumutor Description and Business Overview
    Table 63. Zumutor Oncology Drug Discovery Services Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Oncology Drug Discovery Services Business of Zumutor (2019-2024)
    Table 65. Zumutor Recent Developments
    Table 66. ChemPartner Basic Information List
    Table 67. ChemPartner Description and Business Overview
    Table 68. ChemPartner Oncology Drug Discovery Services Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Oncology Drug Discovery Services Business of ChemPartner (2019-2024)
    Table 70. ChemPartner Recent Developments
    Table 71. Aquila BioMedical Basic Information List
    Table 72. Aquila BioMedical Description and Business Overview
    Table 73. Aquila BioMedical Oncology Drug Discovery Services Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Oncology Drug Discovery Services Business of Aquila BioMedical (2019-2024)
    Table 75. Aquila BioMedical Recent Developments
    Table 76. Onconova Basic Information List
    Table 77. Onconova Description and Business Overview
    Table 78. Onconova Oncology Drug Discovery Services Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Oncology Drug Discovery Services Business of Onconova (2019-2024)
    Table 80. Onconova Recent Developments
    Table 81. Vichem Chemie Basic Information List
    Table 82. Vichem Chemie Description and Business Overview
    Table 83. Vichem Chemie Oncology Drug Discovery Services Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Oncology Drug Discovery Services Business of Vichem Chemie (2019-2024)
    Table 85. Vichem Chemie Recent Developments
    Table 86. GVK Biosciences Basic Information List
    Table 87. GVK Biosciences Description and Business Overview
    Table 88. GVK Biosciences Oncology Drug Discovery Services Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Oncology Drug Discovery Services Business of GVK Biosciences (2019-2024)
    Table 90. GVK Biosciences Recent Developments
    Table 91. NuChem Therapeutics Basic Information List
    Table 92. NuChem Therapeutics Description and Business Overview
    Table 93. NuChem Therapeutics Oncology Drug Discovery Services Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Oncology Drug Discovery Services Business of NuChem Therapeutics (2019-2024)
    Table 95. NuChem Therapeutics Recent Developments
    Table 96. Syncom Basic Information List
    Table 97. Syncom Description and Business Overview
    Table 98. Syncom Oncology Drug Discovery Services Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Oncology Drug Discovery Services Business of Syncom (2019-2024)
    Table 100. Syncom Recent Developments
    Table 101. Envigo Basic Information List
    Table 102. Envigo Description and Business Overview
    Table 103. Envigo Oncology Drug Discovery Services Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Oncology Drug Discovery Services Business of Envigo (2019-2024)
    Table 105. Envigo Recent Developments
    Table 106. DiverChim Basic Information List
    Table 107. DiverChim Description and Business Overview
    Table 108. DiverChim Oncology Drug Discovery Services Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Oncology Drug Discovery Services Business of DiverChim (2019-2024)
    Table 110. DiverChim Recent Developments
    Table 111. Aurora Basic Information List
    Table 112. Aurora Description and Business Overview
    Table 113. Aurora Oncology Drug Discovery Services Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Oncology Drug Discovery Services Business of Aurora (2019-2024)
    Table 115. Aurora Recent Developments
    Table 116. HD Biosciences Basic Information List
    Table 117. HD Biosciences Description and Business Overview
    Table 118. HD Biosciences Oncology Drug Discovery Services Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Oncology Drug Discovery Services Business of HD Biosciences (2019-2024)
    Table 120. HD Biosciences Recent Developments
    Table 121. WuXi AppTec Basic Information List
    Table 122. WuXi AppTec Description and Business Overview
    Table 123. WuXi AppTec Oncology Drug Discovery Services Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Oncology Drug Discovery Services Business of WuXi AppTec (2019-2024)
    Table 125. WuXi AppTec Recent Developments
    Table 126. Key Raw Materials Lists
    Table 127. Raw Materials Key Suppliers Lists
    Table 128. Oncology Drug Discovery Services Downstream Customers
    Table 129. Oncology Drug Discovery Services Distributors List
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
    Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Oncology Drug Discovery Services Product Picture
    Figure 2. Global Oncology Drug Discovery Services Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Oncology Drug Discovery Services Sales Value (2019-2030) & (US$ Million)
    Figure 4. Oncology Drug Discovery Services Report Years Considered
    Figure 5. Global Oncology Drug Discovery Services Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology Drug Discovery Services Revenue in 2023
    Figure 7. Oncology Drug Discovery Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Identification Service Picture
    Figure 9. Authentication Service Picture
    Figure 10. Hit-to-lead and Lead Optimization Services Picture
    Figure 11. Others Picture
    Figure 12. Global Oncology Drug Discovery Services Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Oncology Drug Discovery Services Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Research Institutes
    Figure 15. Product Picture of Pharmaceutical Companies
    Figure 16. Product Picture of Biotechnology Companies
    Figure 17. Product Picture of Others
    Figure 18. Global Oncology Drug Discovery Services Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Oncology Drug Discovery Services Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Oncology Drug Discovery Services Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Oncology Drug Discovery Services Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Oncology Drug Discovery Services Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Oncology Drug Discovery Services Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Oncology Drug Discovery Services Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Oncology Drug Discovery Services Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Oncology Drug Discovery Services Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Oncology Drug Discovery Services Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Oncology Drug Discovery Services Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Oncology Drug Discovery Services Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Oncology Drug Discovery Services Sales Value (%), (2019-2030)
    Figure 31. United States Oncology Drug Discovery Services Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Oncology Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Oncology Drug Discovery Services Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Oncology Drug Discovery Services Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Oncology Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Oncology Drug Discovery Services Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Oncology Drug Discovery Services Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Oncology Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Oncology Drug Discovery Services Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Oncology Drug Discovery Services Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Oncology Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Oncology Drug Discovery Services Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Oncology Drug Discovery Services Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Oncology Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Oncology Drug Discovery Services Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Oncology Drug Discovery Services Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Oncology Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Oncology Drug Discovery Services Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Oncology Drug Discovery Services Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Oncology Drug Discovery Services Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Oncology Drug Discovery Services Sales Value by Application (%), 2023 VS 2030
    Figure 52. Oncology Drug Discovery Services Industrial Chain
    Figure 53. Oncology Drug Discovery Services Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

OSZAR »